LEONARD E. POST - 06 Dec 2024 Form 4 Insider Report for CG Oncology, Inc. (CGON)

Role
Director
Signature
/s/ Joshua F. Patterson, Attorney-in-Fact for Leonard Post
Issuer symbol
CGON
Transactions as of
06 Dec 2024
Net transactions value
-$33,942
Form type
4
Filing time
06 Dec 2024, 18:51:46 UTC
Previous filing
07 Oct 2024
Next filing
17 Dec 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CGON Common Stock Options Exercise $600 +1,000 $0.6000 1,000 06 Dec 2024 Direct
transaction CGON Common Stock Sale $25,798 -750 -75% $34.40 250 06 Dec 2024 Direct F1, F2
transaction CGON Common Stock Sale $8,744 -250 -100% $34.98 0 06 Dec 2024 Direct F1, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CGON Stock Option Options Exercise $0 -1,000 -0.74% $0.000000 134,077 06 Dec 2024 Common Stock 1,000 $0.6000 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 6, 2024.
F2 Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $33.91 to $34.87. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.
F3 Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $34.92 to $35.05. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.
F4 Fully vested.